Chemed Corporation (NYSE:CHE) Receives Consensus Recommendation of “Hold” from Analysts

Chemed Corporation (NYSE:CHE) has earned an average recommendation of “Hold” from the six analysts that are covering the company, MarketBeat.com reports. Five analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $530.75.

CHE has been the subject of a number of recent analyst reports. Oppenheimer upped their price objective on Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. Bank of America reiterated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Royal Bank Of Canada boosted their price target on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a report on Thursday, July 30th. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a research report on Saturday, August 1st. Finally, Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th.

Insider Transactions at Chemed

In other news, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director owned 4,578 shares in the company, valued at $2,047,876.74. This trade represents a 22.73% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Patrick P. Grace sold 190 shares of Chemed stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the completion of the sale, the director directly owned 3,533 shares in the company, valued at $1,879,556. This trade represents a 5.10% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 3,537 shares of company stock worth $1,782,654 in the last quarter. Insiders own 3.33% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Monetary Solutions Ltd bought a new position in shares of Chemed during the 4th quarter worth $25,000. Los Angeles Capital Management LLC purchased a new stake in Chemed during the fourth quarter valued at about $26,000. BOK Financial Private Wealth Inc. purchased a new stake in Chemed during the fourth quarter valued at about $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Chemed during the second quarter worth about $34,000. Finally, Versant Capital Management Inc boosted its position in Chemed by 7,500.0% during the second quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after purchasing an additional 75 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Price Performance

Shares of NYSE CHE opened at $541.33 on Monday. Chemed has a twelve month low of $365.20 and a twelve month high of $557.00. The stock’s 50 day moving average price is $499.24 and its 200-day moving average price is $446.50. The company has a market capitalization of $7.08 billion, a PE ratio of 27.19, a PEG ratio of 2.05 and a beta of 0.51. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.Chemed’s revenue was up 8.8% on a year-over-year basis. During the same period last year, the business posted $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, equities analysts anticipate that Chemed will post 23.18 EPS for the current year.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be given a dividend of $0.70 per share. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. This is an increase from Chemed’s previous quarterly dividend of $0.60. Chemed’s payout ratio is currently 14.06%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.